P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

June 2008

Features

Letter to the Editor

Aliskiren Reduces Plasma Renin Activity

Marjorie Gatlin, MD

Cover Story

Challenges in Evaluating and Standardizing Medical Devices in Health Care Facilities

Advances in medical technologies have led to improved diagnoses and treatments, but medical devices do not always undergo the rigorous review process that is applied to drugs. To control costs, some health care facilities are becoming more selective in how they evaluate new devices.
C. Lee Ventola, MS

Technology

California e-Pedigree Rules Pose Challenges for Pharmacies

Because of the complex process involved in adding bar codes to all drug packages in order to prevent fraud, it might be difficult for pharmacies to fulfill the requirements of the e-Pedigree law, even by the target date of 2011.
Stephen Barlas

Pharmaceutical Approval Update

Medically accepted off-label uses of azacitidine (Vidaza) and a new indication for lubiprostone (Amitiza) are discussed.
Marvin M. Goldenberg, PhD, RPh, MS

Meeting Highlights

American Psychiatric Association

Presentations cover iloperidone (Fanapta) for schizophrenia, asenapine for bipolar disorder, and virtual reality sessions for patients with post-traumatic stress disorder.
Walter Alexander

P&T Snapshot

At a Glance: Dermatology Trends In Managed Care

According to a 2007 report, most dermatologists predicted that biologic therapies would be used more frequently in the next year; did not follow formularies they considered too restrictive; and expressed concern about denials of paper claims and reimbursements for surgical procedures combined with office visits.
Noah Scheinfeld, MD, John Jesitus, MA, and Peter Sonnenreich, MA

Departments

Editorial

Career Advice

David Nash, MD, MBA, offers strategies for current workers and young people preparing to enter an evolving pharmaceutical industry.
David B. Nash, MD, MBA

Medication Errors

The High Cost of Medications

Matthew Grissinger, RPh, FASCP, reports on a survey in which many respondents said they had put off filling prescriptions, cut back on doses, or bought drugs illegally from other countries because of the high cost of prescribed drugs.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

FDA Review of Drug Ads Doesn’t Add Up

Stephen Barlas discusses the damage that can be done when the FDA does not approve drug ads before they are broadcast on television.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

From Advair to Taclonex, P&T presents the latest information about FDA approvals, new indications, recalls, and industry updates.

Drug Forecast

Etonogestrel (Implanon), Another Treatment Option for Contraception

Drs. Maddox and Rahman review etonogestrel ­(Im­planon), a contraceptive.
Dionne D. Maddox, PharmD, and Zahra Rahman, PharmD